ID   AL1A1_HUMAN             Reviewed;         501 AA.
AC   P00352; O00768; Q5SYR1;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   10-MAY-2017, entry version 185.
DE   RecName: Full=Retinal dehydrogenase 1 {ECO:0000305};
DE            Short=RALDH 1 {ECO:0000305};
DE            Short=RalDH1 {ECO:0000305};
DE            EC=1.2.1.- {ECO:0000269|PubMed:19296407, ECO:0000269|PubMed:25450233, ECO:0000269|PubMed:26373694};
DE            EC=1.2.1.36 {ECO:0000250|UniProtKB:P51647};
DE   AltName: Full=ALDH-E1;
DE   AltName: Full=ALHDII;
DE   AltName: Full=Aldehyde dehydrogenase family 1 member A1 {ECO:0000312|HGNC:HGNC:402};
DE   AltName: Full=Aldehyde dehydrogenase, cytosolic {ECO:0000303|PubMed:2591967};
GN   Name=ALDH1A1 {ECO:0000312|HGNC:HGNC:402};
GN   Synonyms=ALDC, ALDH1 {ECO:0000312|HGNC:HGNC:402},
GN   PUMB1 {ECO:0000312|HGNC:HGNC:402};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2591967; DOI=10.1016/0888-7543(89)90127-4;
RA   Hsu L.C., Chang W.-C., Yoshida A.;
RT   "Genomic structure of the human cytosolic aldehyde dehydrogenase
RT   gene.";
RL   Genomics 5:857-865(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT SER-121.
RC   TISSUE=Liver;
RX   PubMed=8214422; DOI=10.1111/j.1530-0277.1993.tb00849.x;
RA   Zheng C.F., Wang T.T., Weiner H.;
RT   "Cloning and expression of the full-length cDNAs encoding human liver
RT   class 1 and class 2 aldehyde dehydrogenase.";
RL   Alcohol. Clin. Exp. Res. 17:828-831(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND ENZYME REGULATION.
RC   TISSUE=Lens;
RX   PubMed=19296407; DOI=10.1080/15287390802706371;
RA   Xiao T., Shoeb M., Siddiqui M.S., Zhang M., Ramana K.V.,
RA   Srivastava S.K., Vasiliou V., Ansari N.H.;
RT   "Molecular cloning and oxidative modification of human lens ALDH1A1:
RT   implication in impaired detoxification of lipid aldehydes.";
RL   J. Toxicol. Environ. Health Part A 72:577-584(2009).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT PHE-177.
RG   NIEHS SNPs program;
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-6.
RX   PubMed=8493914;
RA   Yoshida A., Hsu L.C., Yanagawa Y.;
RT   "Biological role of human cytosolic aldehyde dehydrogenase 1: hormonal
RT   response, retinal oxidation and implication in testicular
RT   feminization.";
RL   Adv. Exp. Med. Biol. 328:37-44(1993).
RN   [10]
RP   PROTEIN SEQUENCE OF 2-501, AND ACETYLATION AT SER-2.
RC   TISSUE=Liver;
RX   PubMed=6723659; DOI=10.1111/j.1432-1033.1984.tb08150.x;
RA   Hempel J., von Bahr-Lindstroem H., Joernvall H.;
RT   "Aldehyde dehydrogenase from human liver. Primary structure of the
RT   cytoplasmic isoenzyme.";
RL   Eur. J. Biochem. 141:21-35(1984).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 162-501.
RX   PubMed=4015823; DOI=10.1016/0741-8329(85)90024-2;
RA   Yoshida A., Ikawa M., Hsu L.C., Tani K.;
RT   "Molecular abnormality and cDNA cloning of human aldehyde
RT   dehydrogenases.";
RL   Alcohol 2:103-106(1985).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 162-501.
RC   TISSUE=Liver;
RX   PubMed=2987944; DOI=10.1073/pnas.82.11.3771;
RA   Hsu L.C., Tani K., Fujiyoshi T., Kurachi K., Yoshida A.;
RT   "Cloning of cDNAs for human aldehyde dehydrogenases 1 and 2.";
RL   Proc. Natl. Acad. Sci. U.S.A. 82:3771-3775(1985).
RN   [13]
RP   PROTEIN SEQUENCE OF 266-273, ACTIVE SITES GLU-269 AND CYS-303, AND
RP   NAD-BINDING SITE CYS-456.
RX   PubMed=3676276; DOI=10.1021/bi00392a015;
RA   Abriola D.P., Fields R., Stein S., Mackerell A.D. Jr., Pietruszko R.;
RT   "Active site of human liver aldehyde dehydrogenase.";
RL   Biochemistry 26:5679-5684(1987).
RN   [14]
RP   PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Erythrocyte;
RX   PubMed=2776714;
RA   Agarwal D.P., Cohn P., Goedde H.W., Hempel J.;
RT   "Aldehyde dehydrogenase from human erythrocytes: structural
RT   relationship to the liver cytosolic isozyme.";
RL   Enzyme 42:47-52(1989).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-91; LYS-128; LYS-252;
RP   LYS-353; LYS-367; LYS-410; LYS-419; LYS-435 AND LYS-495, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [17]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-337 AND SER-413, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) IN COMPLEX WITH DUOCARMYCIN
RP   ANALOG, FUNCTION, CATALYTIC ACTIVITY, ENZYME REGULATION, AND
RP   MUTAGENESIS OF CYS-302.
RX   PubMed=26373694; DOI=10.1002/anie.201505749;
RA   Koch M.F., Harteis S., Blank I.D., Pestel G., Tietze L.F.,
RA   Ochsenfeld C., Schneider S., Sieber S.A.;
RT   "Structural, biochemical, and computational studies reveal the
RT   mechanism of selective aldehyde dehydrogenase 1A1 inhibition by
RT   cytotoxic duocarmycin analogues.";
RL   Angew. Chem. Int. Ed. Engl. 54:13550-13554(2015).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (1.74 ANGSTROMS) OF VARIANT SER-121 ALONE AND IN
RP   COMPLEX WITH NADH, FUNCTION, CATALYTIC ACTIVITY, AND
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=25450233; DOI=10.1016/j.cbi.2014.10.028;
RA   Morgan C.A., Hurley T.D.;
RT   "Development of a high-throughput in vitro assay to identify selective
RT   inhibitors for human ALDH1A1.";
RL   Chem. Biol. Interact. 234:29-37(2015).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) IN COMPLEX WITH NAD AND
RP   INHIBITORS, AND MUTAGENESIS OF GLY-458.
RX   PubMed=25634381; DOI=10.1021/jm501900s;
RA   Morgan C.A., Hurley T.D.;
RT   "Characterization of two distinct structural classes of selective
RT   aldehyde dehydrogenase 1A1 inhibitors.";
RL   J. Med. Chem. 58:1964-1975(2015).
CC   -!- FUNCTION: Can convert/oxidize retinaldehyde to retinoic acid.
CC       Binds free retinal and cellular retinol-binding protein-bound
CC       retinal (By similarity). May have a broader specificity and
CC       oxidize other aldehydes in vivo (PubMed:19296407, PubMed:26373694,
CC       PubMed:25450233). {ECO:0000250|UniProtKB:P51647,
CC       ECO:0000269|PubMed:19296407, ECO:0000269|PubMed:25450233,
CC       ECO:0000269|PubMed:26373694}.
CC   -!- CATALYTIC ACTIVITY: Retinal + NAD(+) + H(2)O = retinoate + NADH.
CC       {ECO:0000250|UniProtKB:P51647}.
CC   -!- ENZYME REGULATION: Inhibited by citral, disulfiram, and cyanamide.
CC       Activated by diethylstilbestrol (PubMed:19296407). Inhibited by
CC       duocarmycin analogs (PubMed:26373694).
CC       {ECO:0000269|PubMed:19296407, ECO:0000269|PubMed:26373694}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=59.4 uM for NAD (at pH 8.0) {ECO:0000269|PubMed:19296407};
CC         KM=238.2 uM for acetaldehyde (at pH 8.0)
CC         {ECO:0000269|PubMed:19296407};
CC         KM=142.2 uM for benzaldehyde (at pH 8.0)
CC         {ECO:0000269|PubMed:19296407};
CC         KM=4.8 uM for 4-hydroxynonenal (at pH 8.0)
CC         {ECO:0000269|PubMed:19296407};
CC         KM=121.4 uM for propionaldehyde (at pH 8.0)
CC         {ECO:0000269|PubMed:19296407};
CC         KM=15 uM for propionaldehyde (at pH 7.5)
CC         {ECO:0000269|PubMed:25450233};
CC         KM=3.5 uM for malonaldehyde (at pH 8.0)
CC         {ECO:0000269|PubMed:19296407};
CC         KM=177.1 uM for trans-2-heptenal (at pH 8.0)
CC         {ECO:0000269|PubMed:19296407};
CC         Vmax=149.7 nmol/min/mg enzyme with NAD (at pH 8.0)
CC         {ECO:0000269|PubMed:19296407};
CC         Vmax=631.4 nmol/min/mg enzyme with acetaldehyde (at pH 8.0)
CC         {ECO:0000269|PubMed:19296407};
CC         Vmax=750.3 nmol/min/mg enzyme with benzaldehyde (at pH 8.0)
CC         {ECO:0000269|PubMed:19296407};
CC         Vmax=135 nmol/min/mg enzyme with 4-hydroxynonenal (at pH 8.0)
CC         {ECO:0000269|PubMed:19296407};
CC         Vmax=445.3 nmol/min/mg enzyme with propionaldehyde (at pH 8.0)
CC         {ECO:0000269|PubMed:19296407};
CC         Vmax=381.6 nmol/min/mg enzyme with malonaldehyde (at pH 8.0)
CC         {ECO:0000269|PubMed:19296407};
CC         Vmax=155.8 nmol/min/mg enzyme with trans-2-heptenal (at pH 8.0)
CC         {ECO:0000269|PubMed:19296407};
CC   -!- PATHWAY: Cofactor metabolism; retinol metabolism.
CC       {ECO:0000250|UniProtKB:P51647}.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000250|UniProtKB:P51977}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol
CC       {ECO:0000250|UniProtKB:P48644}.
CC   -!- PTM: The N-terminus is blocked most probably by acetylation.
CC       {ECO:0000250|UniProtKB:P15437}.
CC   -!- SIMILARITY: Belongs to the aldehyde dehydrogenase family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/aldh1a1/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M31994; AAA51692.1; -; Genomic_DNA.
DR   EMBL; M31982; AAA51692.1; JOINED; Genomic_DNA.
DR   EMBL; M31983; AAA51692.1; JOINED; Genomic_DNA.
DR   EMBL; M31984; AAA51692.1; JOINED; Genomic_DNA.
DR   EMBL; M31985; AAA51692.1; JOINED; Genomic_DNA.
DR   EMBL; M31986; AAA51692.1; JOINED; Genomic_DNA.
DR   EMBL; M31987; AAA51692.1; JOINED; Genomic_DNA.
DR   EMBL; M31988; AAA51692.1; JOINED; Genomic_DNA.
DR   EMBL; M31989; AAA51692.1; JOINED; Genomic_DNA.
DR   EMBL; M31990; AAA51692.1; JOINED; Genomic_DNA.
DR   EMBL; M31991; AAA51692.1; JOINED; Genomic_DNA.
DR   EMBL; M31992; AAA51692.1; JOINED; Genomic_DNA.
DR   EMBL; AF003341; AAC51652.1; -; mRNA.
DR   EMBL; AY390731; AAR92229.1; -; mRNA.
DR   EMBL; BT006921; AAP35567.1; -; mRNA.
DR   EMBL; AY338497; AAP88039.1; -; Genomic_DNA.
DR   EMBL; AL591031; CAI12257.1; -; Genomic_DNA.
DR   EMBL; CH471089; EAW62543.1; -; Genomic_DNA.
DR   EMBL; BC001505; AAH01505.1; -; mRNA.
DR   EMBL; S61235; AAD13925.1; -; Genomic_DNA.
DR   EMBL; M26761; AAA35518.1; -; mRNA.
DR   EMBL; K03000; AAA51695.1; -; mRNA.
DR   CCDS; CCDS6644.1; -.
DR   PIR; A33371; DEHUE1.
DR   RefSeq; NP_000680.2; NM_000689.4.
DR   UniGene; Hs.76392; -.
DR   PDB; 4WB9; X-ray; 2.07 A; A=1-501.
DR   PDB; 4WJ9; X-ray; 1.74 A; A=1-501.
DR   PDB; 4WP7; X-ray; 1.80 A; A=1-501.
DR   PDB; 4WPN; X-ray; 1.95 A; A=1-501.
DR   PDB; 4X4L; X-ray; 1.85 A; A=1-501.
DR   PDB; 5AC2; X-ray; 1.85 A; A=1-501.
DR   PDB; 5L2M; X-ray; 1.70 A; A=1-501.
DR   PDB; 5L2N; X-ray; 1.70 A; A=1-501.
DR   PDB; 5L2O; X-ray; 2.05 A; A/B/C/D/E/F/G/H=1-501.
DR   PDBsum; 4WB9; -.
DR   PDBsum; 4WJ9; -.
DR   PDBsum; 4WP7; -.
DR   PDBsum; 4WPN; -.
DR   PDBsum; 4X4L; -.
DR   PDBsum; 5AC2; -.
DR   PDBsum; 5L2M; -.
DR   PDBsum; 5L2N; -.
DR   PDBsum; 5L2O; -.
DR   ProteinModelPortal; P00352; -.
DR   SMR; P00352; -.
DR   BioGrid; 106718; 6.
DR   IntAct; P00352; 7.
DR   MINT; MINT-4999613; -.
DR   STRING; 9606.ENSP00000297785; -.
DR   BindingDB; P00352; -.
DR   ChEMBL; CHEMBL3577; -.
DR   DrugBank; DB00157; NADH.
DR   DrugBank; DB00755; Tretinoin.
DR   DrugBank; DB00162; Vitamin A.
DR   iPTMnet; P00352; -.
DR   PhosphoSitePlus; P00352; -.
DR   SwissPalm; P00352; -.
DR   BioMuta; ALDH1A1; -.
DR   DMDM; 118495; -.
DR   DOSAC-COBS-2DPAGE; P00352; -.
DR   REPRODUCTION-2DPAGE; IPI00218914; -.
DR   REPRODUCTION-2DPAGE; P00352; -.
DR   SWISS-2DPAGE; P00352; -.
DR   UCD-2DPAGE; P00352; -.
DR   EPD; P00352; -.
DR   PaxDb; P00352; -.
DR   PeptideAtlas; P00352; -.
DR   PRIDE; P00352; -.
DR   DNASU; 216; -.
DR   Ensembl; ENST00000297785; ENSP00000297785; ENSG00000165092.
DR   GeneID; 216; -.
DR   KEGG; hsa:216; -.
DR   CTD; 216; -.
DR   DisGeNET; 216; -.
DR   GeneCards; ALDH1A1; -.
DR   HGNC; HGNC:402; ALDH1A1.
DR   HPA; CAB020690; -.
DR   HPA; HPA002123; -.
DR   MIM; 100640; gene.
DR   neXtProt; NX_P00352; -.
DR   OpenTargets; ENSG00000165092; -.
DR   PharmGKB; PA24692; -.
DR   eggNOG; KOG2450; Eukaryota.
DR   eggNOG; COG1012; LUCA.
DR   GeneTree; ENSGT00760000118999; -.
DR   HOGENOM; HOG000271505; -.
DR   HOVERGEN; HBG000097; -.
DR   InParanoid; P00352; -.
DR   KO; K07249; -.
DR   OMA; EWHSSVS; -.
DR   OrthoDB; EOG091G05E8; -.
DR   PhylomeDB; P00352; -.
DR   TreeFam; TF300455; -.
DR   BioCyc; MetaCyc:HS09183-MONOMER; -.
DR   Reactome; R-HSA-5365859; RA biosynthesis pathway.
DR   Reactome; R-HSA-70350; Fructose catabolism.
DR   Reactome; R-HSA-71384; Ethanol oxidation.
DR   SABIO-RK; P00352; -.
DR   UniPathway; UPA00912; -.
DR   ChiTaRS; ALDH1A1; human.
DR   GeneWiki; ALDH1A1; -.
DR   GenomeRNAi; 216; -.
DR   PRO; PR:P00352; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000165092; -.
DR   CleanEx; HS_ALDH1A1; -.
DR   ExpressionAtlas; P00352; baseline and differential.
DR   Genevisible; P00352; HS.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0004029; F:aldehyde dehydrogenase (NAD) activity; IDA:UniProtKB.
DR   GO; GO:0005497; F:androgen binding; TAS:ProtInc.
DR   GO; GO:0018479; F:benzaldehyde dehydrogenase (NAD+) activity; IBA:GO_Central.
DR   GO; GO:0005096; F:GTPase activator activity; TAS:UniProtKB.
DR   GO; GO:0051287; F:NAD binding; ISS:CAFA.
DR   GO; GO:0001758; F:retinal dehydrogenase activity; ISS:UniProtKB.
DR   GO; GO:0006081; P:cellular aldehyde metabolic process; TAS:ProtInc.
DR   GO; GO:0006069; P:ethanol oxidation; TAS:Reactome.
DR   GO; GO:0061624; P:fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate; TAS:Reactome.
DR   GO; GO:0055114; P:oxidation-reduction process; IDA:UniProtKB.
DR   GO; GO:0001523; P:retinoid metabolic process; ISS:UniProtKB.
DR   GO; GO:0042572; P:retinol metabolic process; IEA:UniProtKB-UniPathway.
DR   Gene3D; 3.40.605.10; -; 1.
DR   InterPro; IPR016161; Ald_DH/histidinol_DH.
DR   InterPro; IPR016160; Ald_DH_CS_CYS.
DR   InterPro; IPR029510; Ald_DH_CS_GLU.
DR   InterPro; IPR016162; Ald_DH_N.
DR   InterPro; IPR015590; Aldehyde_DH_dom.
DR   Pfam; PF00171; Aldedh; 1.
DR   SUPFAM; SSF53720; SSF53720; 1.
DR   PROSITE; PS00070; ALDEHYDE_DEHYDR_CYS; 1.
DR   PROSITE; PS00687; ALDEHYDE_DEHYDR_GLU; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; NAD; Nucleotide-binding; Oxidoreductase;
KW   Phosphoprotein; Polymorphism; Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22223895,
FT                                ECO:0000269|PubMed:6723659}.
FT   CHAIN         2    501       Retinal dehydrogenase 1.
FT                                /FTId=PRO_0000056415.
FT   NP_BIND     167    170       NAD. {ECO:0000244|PDB:4WB9,
FT                                ECO:0000244|PDB:4X4L}.
FT   NP_BIND     193    196       NAD. {ECO:0000244|PDB:4WB9,
FT                                ECO:0000244|PDB:4X4L}.
FT   NP_BIND     226    227       NAD. {ECO:0000244|PDB:4WB9,
FT                                ECO:0000244|PDB:4X4L}.
FT   NP_BIND     246    247       NAD. {ECO:0000244|PDB:4WB9,
FT                                ECO:0000244|PDB:4X4L}.
FT   NP_BIND     269    271       NAD. {ECO:0000244|PDB:4WB9,
FT                                ECO:0000244|PDB:4X4L}.
FT   NP_BIND     349    353       NAD. {ECO:0000244|PDB:4WB9,
FT                                ECO:0000244|PDB:4X4L}.
FT   NP_BIND     400    402       NAD. {ECO:0000244|PDB:4WB9,
FT                                ECO:0000244|PDB:4X4L}.
FT   ACT_SITE    269    269       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10007, ECO:0000255|PROSITE-
FT                                ProRule:PRU10008,
FT                                ECO:0000269|PubMed:3676276}.
FT   ACT_SITE    303    303       Nucleophile. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10007, ECO:0000255|PROSITE-
FT                                ProRule:PRU10008,
FT                                ECO:0000269|PubMed:3676276}.
FT   SITE        170    170       Transition state stabilizer.
FT                                {ECO:0000250|UniProtKB:P20000}.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000244|PubMed:22223895,
FT                                ECO:0000269|PubMed:6723659}.
FT   MOD_RES      91     91       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     128    128       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     252    252       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     337    337       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     353    353       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     367    367       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     410    410       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     413    413       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     419    419       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     435    435       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     495    495       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VARIANT     121    121       N -> S (in dbSNP:rs1049981).
FT                                {ECO:0000269|PubMed:8214422}.
FT                                /FTId=VAR_048901.
FT   VARIANT     125    125       G -> R (in dbSNP:rs11554423).
FT                                /FTId=VAR_048902.
FT   VARIANT     177    177       I -> F (in dbSNP:rs8187929).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_017778.
FT   MUTAGEN     302    302       C->A,S: Does not prevent inhibition by
FT                                duocarmycin analogs.
FT                                {ECO:0000269|PubMed:26373694}.
FT   MUTAGEN     458    458       G->N: No significant effect on aldehyde
FT                                dehydrogenase activity. Prevents the
FT                                inhibition by ALDH1A1-specific
FT                                inhibitors.
FT                                {ECO:0000269|PubMed:25634381}.
FT   CONFLICT    162    162       V -> I (in Ref. 11; AAA35518 and 12;
FT                                AAA51695). {ECO:0000305}.
FT   STRAND       22     25       {ECO:0000244|PDB:4WJ9}.
FT   STRAND       28     30       {ECO:0000244|PDB:4WJ9}.
FT   STRAND       37     41       {ECO:0000244|PDB:4WJ9}.
FT   TURN         43     45       {ECO:0000244|PDB:4WJ9}.
FT   STRAND       48     53       {ECO:0000244|PDB:4WJ9}.
FT   HELIX        57     71       {ECO:0000244|PDB:4WJ9}.
FT   HELIX        76     79       {ECO:0000244|PDB:4WJ9}.
FT   HELIX        82     98       {ECO:0000244|PDB:4WJ9}.
FT   HELIX       100    111       {ECO:0000244|PDB:4WJ9}.
FT   HELIX       115    120       {ECO:0000244|PDB:4WJ9}.
FT   HELIX       122    136       {ECO:0000244|PDB:4WJ9}.
FT   HELIX       137    139       {ECO:0000244|PDB:4WJ9}.
FT   STRAND      148    159       {ECO:0000244|PDB:4WJ9}.
FT   STRAND      162    166       {ECO:0000244|PDB:4WJ9}.
FT   STRAND      169    171       {ECO:0000244|PDB:4WJ9}.
FT   HELIX       172    185       {ECO:0000244|PDB:4WJ9}.
FT   STRAND      189    193       {ECO:0000244|PDB:4WJ9}.
FT   HELIX       200    212       {ECO:0000244|PDB:4WJ9}.
FT   STRAND      218    221       {ECO:0000244|PDB:4WJ9}.
FT   TURN        226    228       {ECO:0000244|PDB:4WJ9}.
FT   HELIX       229    235       {ECO:0000244|PDB:4WJ9}.
FT   STRAND      241    246       {ECO:0000244|PDB:4WJ9}.
FT   HELIX       248    260       {ECO:0000244|PDB:4WJ9}.
FT   STRAND      265    269       {ECO:0000244|PDB:4WJ9}.
FT   STRAND      275    278       {ECO:0000244|PDB:4WJ9}.
FT   HELIX       284    296       {ECO:0000244|PDB:4WJ9}.
FT   HELIX       297    300       {ECO:0000244|PDB:4WJ9}.
FT   STRAND      308    312       {ECO:0000244|PDB:4WJ9}.
FT   HELIX       313    327       {ECO:0000244|PDB:4WJ9}.
FT   HELIX       348    363       {ECO:0000244|PDB:4WJ9}.
FT   STRAND      367    370       {ECO:0000244|PDB:4WJ9}.
FT   STRAND      373    379       {ECO:0000244|PDB:4WJ9}.
FT   STRAND      385    389       {ECO:0000244|PDB:4WJ9}.
FT   HELIX       395    398       {ECO:0000244|PDB:4WJ9}.
FT   STRAND      403    412       {ECO:0000244|PDB:4WJ9}.
FT   HELIX       414    422       {ECO:0000244|PDB:4WJ9}.
FT   STRAND      428    433       {ECO:0000244|PDB:4WJ9}.
FT   HELIX       437    446       {ECO:0000244|PDB:4WJ9}.
FT   STRAND      450    455       {ECO:0000244|PDB:4WJ9}.
FT   HELIX       470    472       {ECO:0000244|PDB:4WJ9}.
FT   STRAND      473    475       {ECO:0000244|PDB:4WJ9}.
FT   HELIX       479    483       {ECO:0000244|PDB:4WJ9}.
FT   HELIX       484    486       {ECO:0000244|PDB:4WJ9}.
FT   STRAND      487    495       {ECO:0000244|PDB:4WJ9}.
SQ   SEQUENCE   501 AA;  54862 MW;  B26464DC7168348E CRC64;
     MSSSGTPDLP VLLTDLKIQY TKIFINNEWH DSVSGKKFPV FNPATEEELC QVEEGDKEDV
     DKAVKAARQA FQIGSPWRTM DASERGRLLY KLADLIERDR LLLATMESMN GGKLYSNAYL
     NDLAGCIKTL RYCAGWADKI QGRTIPIDGN FFTYTRHEPI GVCGQIIPWN FPLVMLIWKI
     GPALSCGNTV VVKPAEQTPL TALHVASLIK EAGFPPGVVN IVPGYGPTAG AAISSHMDID
     KVAFTGSTEV GKLIKEAAGK SNLKRVTLEL GGKSPCIVLA DADLDNAVEF AHHGVFYHQG
     QCCIAASRIF VEESIYDEFV RRSVERAKKY ILGNPLTPGV TQGPQIDKEQ YDKILDLIES
     GKKEGAKLEC GGGPWGNKGY FVQPTVFSNV TDEMRIAKEE IFGPVQQIMK FKSLDDVIKR
     ANNTFYGLSA GVFTKDIDKA ITISSALQAG TVWVNCYGVV SAQCPFGGFK MSGNGRELGE
     YGFHEYTEVK TVTVKISQKN S
//
